key: cord-0056674-29okh8l1
authors: nan
title: COVID-19 vaccine safety monitoring
date: 2021-02-27
journal: Reactions Weekly
DOI: 10.1007/s40278-021-91448-x
sha: a6e2563f3883955f5d9ca796180499aca88ef231
doc_id: 56674
cord_uid: 29okh8l1

nan

The Danish Medicines Agency (DMA) is expanded capacity for safety monitoring of COVID-19 vaccines in Denmark. 2 Thousands of Danish citizens have already undergone COVID-19 vaccination and shortly the rest of the population is expected to be offered vaccination. To ensure intensive and close monitoring of the COVID-19 vaccines, the DMA is increasing its capacity by recruiting more employees to process reports of suspected AEs; it is recruiting 15-20 additional employees in preparation for processing reported AEs once COVID-19 vaccination is rolled out across Denmark.

Therapeutic Goods Administration. COVID-19 vaccine safety monitoring plan. Internet Document : 9

Danish Medicines Agency expands capacity for safety monitoring of COVID-19 vaccines

Adis © 2021 Springer Nature Switzerland AG. All rights reserved